ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance

NCT04429152 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Doravirine/Lamivudine/Tenofovir

Sponsor

Professor Francois Venter